Primary mucosal sinonasal melanoma—Case report and review of the literature. The role of complex treatment-surgery and adjuvant radiotherapy
✍ Scribed by Lena Marinova; Kaloyan Yordanov; Nikolay Sapundgiev
- Publisher
- Wielkopolskie Centrum Onkologii
- Year
- 2011
- Tongue
- Polish
- Weight
- 356 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1507-1367
No coin nor oath required. For personal study only.
✦ Synopsis
Aim:
The place of adjuvant radiotherapy in the treatment of sinonasal melanoma.
Background:
Sinonasal mucosal melanoma is a rare disease with poor prognosis and requires a complex treatment. elective neck dissection in patients with n0 and adjuvant radiotherapy has been a source of controversy. high late regional recurrence rates rise questions about elective irradiation of the neck nodes in patients with n0 stage disease.
Methods:
We present our two years' follow up in a case of locally advanced sinonasal melanoma and literature review of the treatment options for mucosal melanoma.
Results:
In locally advanced sinonasal melanoma treated with surgical resection, postoperative radiotherapy and chemotherapy we had local tumor control. two years later, a regional contralateral recurrence without distant metastasis occurred.
Conclusions:
Literature data for frequent neck lymph nodes recurrences justify elective neck dissection. postoperative elective neck radiotherapy for patients with locally advanced sinonasal melanoma and clinically n0 appears to decrease the rate of late regional recurrences.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The current retrospective study was undertaken to evaluate the treatment outcomes of patients with meningeal hemangiopericytoma (M‐HPC), to define the role of radiotherapy in the management of the disease, and to report on the patterns of failure. ## METHODS The medical
and Review of the Literature BACKGROUND. Experience in the treatment of laryngeal chondrosarcoma is based Stephan Gripp, M.D. on about 250 cases reported to date. The standard therapy is conservative surgery.